FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015891571> ?p ?o ?g. }

• W2015891571 endingPage "368" @default.
• W2015891571 startingPage "360" @default.
• W2015891571 abstract "Periprosthetic granulomatous membranes consisting of fibroblasts, macrophages, lymphocytes, foreign body giant cells, and abundant particulate debris occur at sites of implant loosening. Previous studies demonstrate that fibroblasts respond to particulate debris through the release of interleukin-6 (IL-6), prostaglandin E(2), and matrix metalloproteinases in vitro. C-C chemokines are observed in granulomatous tissue surrounding loosened prosthetic implants and are released by macrophages and fibroblasts in response to particle challenge in vitro. This study tested the hypothesis that G protein activity is required for fibroblast activation by titanium and polymethylmethacrylate (PMMA) particles, and that inhibition of G protein activity would alter IL-6 and and monocyte chemoattractant protein-1 (MCP-1) release from activated fibroblasts. The specific inhibitor of G protein activity, pertussis toxin, was added to the fibroblasts to examine the effects of G protein activity with respect to the production of IL-6 and MCP-1 by orthopedic biomaterial-challenged fibroblasts in vitro. Interleukin-1beta (IL-1beta), a proven activator of MCP-1 and interleukin-6, was used as a positive control. Exposure of fibroblasts to titanium and polymethylmethacrylate (PMMA) particles resulted in a dose-dependent release of MCP-1 and IL-6. Challenge with PMMA particles at doses of 0.150%, 0.300%, and 0.600% vol/vol increased the release of interleukin-6 by 7-, 19-, and 22-fold, respectively, compared to fibroblasts exposed to serum-free culture medium alone at 24 h. Challenge with PMMA particles at doses of 0.075%, 0.150%, 0.300%, and 0.600% vol/vol increased the release of MCP-1-6 by 2.5-, 3.6-, 4. 3-, and 4.5-fold, respectively, compared to fibroblasts exposed to serum-free culture medium alone. Challenge with titanium particles at concentrations of 0.075%, 0.150%, 0.300%, and 0.600% vol/vol increased the release of interleukin-6 by 2.6-, 6.4-, 9.6-, and 10. 0-fold, respectively, compared to fibroblasts exposed to serum-free culture medium alone at 24 h. Challenge with titanium particles at concentrations of 0.038%, 0.075%, 0.150%, 0.300%, and 0.600% vol/vol increased the release of MCP-1 by 2.9-, 3.1-, 5.8-, 5.4-, and 5. 8-fold, respectively, compared to fibroblasts exposed to serum-free culture medium alone. Pretreatment of fibroblasts with pertussis toxin inhibited the release of interleukin-6 and MCP-1 from PMMA and titanium particle challenged fibroblasts in a dose-dependent manner. PMMA particle induced fibroblast IL-6 release was inhibited by 23.6% and 35.3% with 20- and 200-ng/mL doses of pertussis toxin, respectively. Titanium particle induced fibroblast IL-6 release was inhibited by 48.2% and 56.3% with 20- and 200-ng/mL doses of pertussis toxin, respectively. PMMA particle-induced fibroblast MCP-1 release was inhibited by 36.0%, 50.4%, and 60.1% with 2-, 20- and 200-ng/mL doses of pertussis toxin, respectively. Titanium particle-induced fibroblast MCP-1 release was inhibited by 15.5%, 53.2%, and 64.6% with 2-, 20-, and 200-ng/mL doses of pertussis toxin, respectively. This study suggests that fibroblasts localized in periprosthetic membranes are a source of macrophage chemoattractant factors and proinflammatory mediators that may influence granuloma formation and lead to periprosthetic bone resorption. Furthermore, this study shows that G proteins are involved in particle-induced fibroblast activation, as evidenced by decrease levels of particle induced IL-6 and MCP-1 release following pertussis toxin treatment. (c) 2000 John Wiley & Sons, Inc." @default.
• W2015891571 created "2016-06-24" @default.
• W2015891571 creator A5037832313 @default.
• W2015891571 creator A5043053526 @default.
• W2015891571 creator A5050470911 @default.
• W2015891571 creator A5053817793 @default.
• W2015891571 creator A5066854533 @default.
• W2015891571 date "2000-01-01" @default.
• W2015891571 modified "2023-09-26" @default.
• W2015891571 title "G-protein activity requirement for polymethylmethacrylate and titanium particle-induced fibroblast interleukin-6 and monocyte chemoattractant protein-1 releasein vitro" @default.
• W2015891571 cites W1523789654 @default.
• W2015891571 cites W1617966995 @default.
• W2015891571 cites W1908176107 @default.
• W2015891571 cites W1928818161 @default.
• W2015891571 cites W1966090391 @default.
• W2015891571 cites W1968819436 @default.
• W2015891571 cites W1970700880 @default.
• W2015891571 cites W1973724657 @default.
• W2015891571 cites W1974855426 @default.
• W2015891571 cites W1976862940 @default.
• W2015891571 cites W1981878736 @default.
• W2015891571 cites W1985492178 @default.
• W2015891571 cites W1988320618 @default.
• W2015891571 cites W1988885303 @default.
• W2015891571 cites W1993384976 @default.
• W2015891571 cites W1994526714 @default.
• W2015891571 cites W2010661919 @default.
• W2015891571 cites W2011293005 @default.
• W2015891571 cites W2019397766 @default.
• W2015891571 cites W2025505482 @default.
• W2015891571 cites W2026644554 @default.
• W2015891571 cites W2030722999 @default.
• W2015891571 cites W2034952126 @default.
• W2015891571 cites W2038027940 @default.
• W2015891571 cites W2038177927 @default.
• W2015891571 cites W2043431751 @default.
• W2015891571 cites W2051655816 @default.
• W2015891571 cites W2061406376 @default.
• W2015891571 cites W2064914874 @default.
• W2015891571 cites W2068562565 @default.
• W2015891571 cites W2070696078 @default.
• W2015891571 cites W2071499129 @default.
• W2015891571 cites W2074094806 @default.
• W2015891571 cites W2078618689 @default.
• W2015891571 cites W2081171496 @default.
• W2015891571 cites W2088595669 @default.
• W2015891571 cites W2090102588 @default.
• W2015891571 cites W2094862342 @default.
• W2015891571 cites W2100382451 @default.
• W2015891571 cites W2107491460 @default.
• W2015891571 cites W2114460420 @default.
• W2015891571 cites W2119569059 @default.
• W2015891571 cites W2119958553 @default.
• W2015891571 cites W2121686491 @default.
• W2015891571 cites W2126726099 @default.
• W2015891571 cites W2142728021 @default.
• W2015891571 cites W2178410326 @default.
• W2015891571 cites W2181955543 @default.
• W2015891571 cites W2225962314 @default.
• W2015891571 cites W2228466038 @default.
• W2015891571 cites W2243744113 @default.
• W2015891571 cites W2264335976 @default.
• W2015891571 cites W2268968056 @default.
• W2015891571 cites W2273695516 @default.
• W2015891571 cites W2274602153 @default.
• W2015891571 cites W2291088695 @default.
• W2015891571 cites W2308247492 @default.
• W2015891571 cites W2407897584 @default.
• W2015891571 cites W2986888603 @default.
• W2015891571 cites W4211264883 @default.
• W2015891571 cites W4296250016 @default.
• W2015891571 cites W4298824231 @default.
• W2015891571 cites W4299799888 @default.
• W2015891571 doi "https://doi.org/10.1002/1097-4636(20000905)51:3<360::aid-jbm9>3.0.co;2-e" @default.
• W2015891571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10880077" @default.
• W2015891571 hasPublicationYear "2000" @default.
• W2015891571 type Work @default.
• W2015891571 sameAs 2015891571 @default.
• W2015891571 citedByCount "24" @default.
• W2015891571 countsByYear W20158915712012 @default.
• W2015891571 countsByYear W20158915712013 @default.
• W2015891571 countsByYear W20158915712017 @default.
• W2015891571 crossrefType "journal-article" @default.
• W2015891571 hasAuthorship W2015891571A5037832313 @default.
• W2015891571 hasAuthorship W2015891571A5043053526 @default.
• W2015891571 hasAuthorship W2015891571A5050470911 @default.
• W2015891571 hasAuthorship W2015891571A5053817793 @default.
• W2015891571 hasAuthorship W2015891571A5066854533 @default.
• W2015891571 hasConcept C13373296 @default.
• W2015891571 hasConcept C153911025 @default.
• W2015891571 hasConcept C185592680 @default.
• W2015891571 hasConcept C192562407 @default.
• W2015891571 hasConcept C202751555 @default.
• W2015891571 hasConcept C203014093 @default.
• W2015891571 hasConcept C2776914184 @default.
• W2015891571 hasConcept C2778690821 @default.
• W2015891571 hasConcept C2780381497 @default.
• W2015891571 hasConcept C2781184567 @default.

• next